Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine

Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine

<p>Despite progress through expanded use of bed nets and anti-malarial drugs, <em>Plasmodium falciparum</em> (Pf) malaria caused about 200 million cases and 500,000 deaths in 2015. An ideal vaccine would reduce the burden of disease and interrupt transmission. Despite decades of ef...

Detaylı Bibliyografya
Yazar:	Ishizuka, A
Diğer Yazarlar:	Draper, S
Materyal Türü:	Tez
Baskı/Yayın Bilgisi:	2016

Benzer Materyaller

Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Yazar:: Bhatia, Sangeeta
Baskı/Yayın Bilgisi: (2022)

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Yazar:: Zita Sulyok, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
Yazar:: Benjamin Mordmüller, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
Yazar:: Drissa Coulibaly, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adultsResearch in context
Yazar:: Anneth Tumbo, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
Yazar:: Joana C. Silva, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Adaptive clinical trials of three PfSPZ products for development of a whole sporozoite vaccine that prevents <it>Plasmodium falciparum</it> infection, disease and transmission
Yazar:: Hoffman Stephen L
Baskı/Yayın Bilgisi: (2012-10-01)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
Yazar:: Natasha KC, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya
Yazar:: Florence Achieng, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
Yazar:: Sean C Murphy, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Insights into the design of an improved PfRH5 malaria immunogen using vaccine-induced monoclonal antibodies
Yazar:: Alanine, DGW
Baskı/Yayın Bilgisi: (2017)

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Yazar:: Douglas, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5
Yazar:: Khadidiatou Mangou, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Investigation of the Plasmodium falciparum RH5-Interacting Protein (PfRIPR) as a blood-stage malaria vaccine target
Yazar:: Williams, BG
Baskı/Yayın Bilgisi: (2021)

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
Yazar:: Thiam, LG, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
Yazar:: Laty G. Thiam, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
Yazar:: Gustavo Cabral-Miranda, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
Yazar:: Harrison, TE, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
Yazar:: Thomas E Harrison, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines
Yazar:: Cabral-Miranda, G, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
Yazar:: Lucie Jelínková, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Establishment of an Antiplasmodial Vaccine Based on PfRH5-Encoding RNA Replicons Stabilized by Cationic Liposomes
Yazar:: Wesley L. Fotoran, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

RNA Phage VLP-Based Vaccine Platforms
Yazar:: David S. Peabody, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Pre-clinical and clinical development of the first placental malaria vaccine
Yazar:: Caroline Pehrson, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
Yazar:: Jennings, G, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Zika virus-like particle (VLP) based vaccine.
Yazar:: Hélène Boigard, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Optimization of bearing structure of ballast leveling machine SPZ-5/UA
Yazar:: S. A. Kostritsya, ve diğerleri
Baskı/Yayın Bilgisi: (2013-04-01)

Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
Yazar:: Frederica D Partey, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria
Yazar:: Partey, F, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The RH5-CyRPA-Ripr complex as a malaria vaccine target
Yazar:: Ragotte, RJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
Yazar:: Minna M. Hankaniemi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?
Yazar:: Reeshu Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

A DNA Vaccine Encoding <i>Plasmodium falciparum</i> PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization
Yazar:: Wesley Luzetti Fotoran, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
Yazar:: Frederica D Partey, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Targeting PfRh5 on Merozoites to Prevent Basigin Binding
Yazar:: Papadopoulos Konstantinos
Baskı/Yayın Bilgisi: (2012-10-01)

A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
Yazar:: Douglas, A, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells
Yazar:: Ricardo Correia, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
Yazar:: Aline Maria Vasconcelos Queiroz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
Yazar:: Douglas, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants
Yazar:: Bustamante, L, ve diğerleri
Baskı/Yayın Bilgisi: (2013)